Across TCGA pan-cancer cohorts, MIR508 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR508 data layer compared with 11 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR508 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR508 expression acts as an unfavorable survival marker.

LUSC are the cancer types where MIR508 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.192	0.724	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR508 tumor-vs-normal RNA expression · all MIR508 data types